S. Jambon

Direct and Indirect Targeting of HOXA9 Transcription Factor in Acute Myeloid Leukemia

I. Seuningen, M. David-Cordonnier, M. Lambert, 2019, Cancers.

Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell Model.

Daniel P. Sweat, P. Peixoto, W. Wilson, 2019, Journal of medicinal chemistry.

Synthesis, antitumor activity and DNA binding features of benzothiazolyl and benzimidazolyl substituted isoindolines.

G. Karminski-Zamola,, S. Kraljević Pavelić, Nataša Ilić, 2018, Bioorganic & medicinal chemistry.

Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties.

M. Hranjec, G. Karminski-Zamola,, S. Kraljević Pavelić, 2017, European journal of medicinal chemistry.

Targeting Transcription Factors for Cancer Treatment

Sabine Depauw, Mélanie Lambert, Samy Jambon, 2018, Molecules.

Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma

H. Shimada, S. Asgharzadeh, M. Hogarty, 2021, Nature Communications.

Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma

H. Shimada, S. Asgharzadeh, M. Hogarty, 2021, Nature communications.

Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9‐dependent AML

C. Preudhomme, M. Bouhlel, M. Figeac, 2024, HemaSphere.